ロード中...
Clinical evidence for orphan medicinal products-a cause for concern?
BACKGROUND: The difficulties associated with organising clinical studies for orphan medicinal products (OMPs) are plentiful. Recent debate on the long-term effectiveness of some OMPs, led us to question whether the initial standards for clinical evidence for OMPs, set by the European Medicines Agenc...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3852769/ https://ncbi.nlm.nih.gov/pubmed/24131572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-164 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|